| abstract |
The present invention is directed to formula (I) wherein A, R 1 to R 5 are as defined herein, and G is a pyridine, quinoline or pyrimidine group as defined herein. And a pharmaceutically acceptable salt thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their production and their use for the treatment and / or prevention of diseases associated with modulation of SST receptor subtype 5. |